IBBQ · Invesco Nasdaq Biotechnology ETF ETF
Invesco Exchange-Traded Fund Trust II
$35.94
-0.88%
Intraday · Sep 4
Net assets $67,373,541
Holdings252
1 month
+9.52%
Year to date
+28.00%
52-week range
$23.42–$36.84
30-session avg volume
29,750
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000072469
- Report date
- May 31, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Gilead Sciences, Inc. | GILD | $4,979,153 | 7.39% |
| Vertex Pharmaceuticals Inc. | VRTX | $4,969,484 | 7.38% |
| Amgen Inc. | AMGN | $4,786,796 | 7.10% |
| Regeneron Pharmaceuticals, Inc. | REGN | $3,424,325 | 5.08% |
| Alnylam Pharmaceuticals, Inc. | ALNY | $2,147,078 | 3.19% |
| Revolution Medicines, Inc. | RVMD | $1,673,068 | 2.48% |
| Biogen Inc. | BIIB | $1,542,128 | 2.29% |
| Illumina, Inc. | ILMN | $1,335,783 | 1.98% |
| United Therapeutics Corp. | UTHR | $1,308,527 | 1.94% |
| Royalty Pharma PLC | RPRX | $1,280,696 | 1.90% |
| argenx SE | ARGX | $1,271,541 | 1.89% |
| Insmed Inc. | INSM | $1,235,452 | 1.83% |
| Roivant Sciences Ltd. | ROIV | $1,150,716 | 1.71% |
| Incyte Corp. | INCY | $1,032,119 | 1.53% |
| Viatris Inc. | VTRS | $1,003,697 | 1.49% |
| Moderna, Inc. | MRNA | $999,154 | 1.48% |
| Guardant Health, Inc. | GH | $911,980 | 1.35% |
| Neurocrine Biosciences, Inc. | NBIX | $851,812 | 1.26% |
| Jazz Pharmaceuticals PLC | JAZZ | $780,417 | 1.16% |
| Ascendis Pharma A/S | ASND | $739,787 | 1.10% |
| Summit Therapeutics Inc. | SMMT | $729,120 | 1.08% |
| Exelixis, Inc. | EXEL | $702,833 | 1.04% |
| BridgeBio Pharma, Inc. | BBIO | $688,640 | 1.02% |
| Medpace Holdings, Inc. | MEDP | $680,501 | 1.01% |
| Ionis Pharmaceuticals, Inc. | IONS | $677,484 | 1.01% |
| Axsome Therapeutics, Inc. | AXSM | $642,944 | 0.95% |
| Madrigal Pharmaceuticals, Inc. | MDGL | $611,642 | 0.91% |
| BioMarin Pharmaceutical Inc. | BMRN | $590,717 | 0.88% |
| BioNTech SE | BNTX | $586,446 | 0.87% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | $584,870 | 0.87% |
| Sanofi | SNY | $573,038 | 0.85% |
| Praxis Precision Medicines, Inc. | PRAX | $522,505 | 0.78% |
| Cytokinetics, Inc. | CYTK | $506,386 | 0.75% |
| BeOne Medicines Ltd. | ONC | $493,495 | 0.73% |
| Krystal Biotech, Inc. | KRYS | $484,250 | 0.72% |
| Tempus AI, Inc. | TEM | $470,078 | 0.70% |
| Abivax S.A. | ABVX | $436,883 | 0.65% |
| Nuvalent, Inc. | 670703107 | $433,060 | 0.64% |
| Halozyme Therapeutics, Inc. | HALO | $420,999 | 0.62% |
| ImmunityBio, Inc. | IBRX | $414,495 | 0.62% |
| Vaxcyte, Inc. | PCVX | $396,602 | 0.59% |
| Alkermes PLC | ALKS | $376,925 | 0.56% |
| Immunovant, Inc. | IMVT | $363,370 | 0.54% |
| Kymera Therapeutics, Inc. | KYMR | $356,375 | 0.53% |
| Protagonist Therapeutics, Inc. | PTGX | $340,595 | 0.51% |
| Mirum Pharmaceuticals, Inc. | MIRM | $328,353 | 0.49% |
| PTC Therapeutics, Inc. | PTCT | $327,377 | 0.49% |
| Rhythm Pharmaceuticals, Inc. | RYTM | $323,340 | 0.48% |
| Spyre Therapeutics, Inc. | SYRE | $309,215 | 0.46% |
| Cogent Biosciences, Inc. | COGT | $304,222 | 0.45% |